Universitätsklinikum Heidelberg

Hospital


Location: Heidelberg, Germany (DE) DE

ISNI: 0000000103284908

ROR: https://ror.org/013czdx64

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Biology-driven approaches to prevent and treat relapse of myeloid neoplasia after allogeneic hematopoietic stem cell transplantation (2019) Zeiser R, Beelen DW, Bethge W, Bornhäuser M, Bug G, Burchert A, Christopeit M, et al. Journal article Psychosocial distress and utilization of professional psychological care in cancer patients: An observational study in National Comprehensive Cancer Centers (CCCs) in Germany. (2018) Weis J, Hoenig K, Bergelt C, Faller HH, Brechtel A, Hornemann B, Stein B, et al. Journal article Long-peptide vaccination with driver gene mutations in p53 and Kras induces cancer mutation-specific effector as well as regulatory T cell responses (2018) Quandt J, Schlude C, Bartoschek M, Will R, Cid-Arregui A, Schoelch S, Reissfelder C, et al. Journal article Retrospective Analysis of Radiological Recurrence Patterns in Glioblastoma, Their Prognostic Value and Association to Postoperative Infarct Volume (2018) Bette S, Barz M, Huber T, Straube C, Schmidt-Graf F, Combs SE, Delbridge C, et al. Journal article EZH2 Mutations and Impact on Clinical Outcome Analyzed in 1604 Patients with Acute Myeloid Leukemia (2018) Stasik S, Middeke JM, Kraemer M, Rollig C, Kramer A, Scholl S, Hochhaus A, et al. Conference contribution Comorbidities Are Frequent in Older Patients with De Novo Acute Lymphoblastic Leukemia (ALL) and Correlate with Induction Mortality: Analysis of More Than 1200 Patients from GMALL Data Bases (2018) Wermann WK, Viardot A, Kayser S, Alakel N, Elmaagacli A, Faul C, Fiedler W, et al. Conference contribution MOR202 with Low-Dose Dexamethasone (Dex) or Pomalidomide/Dex or Lenalidomide/Dex in Relapsed or Refractory Multiple Myeloma (RRMM): Primary Analysis of a Phase I/IIa, Multicenter, Dose-Escalation Study (2018) Raab MS, Chatterjee M, Goldschmidt H, Agis H, Blau I, Einsele H, Engelhardt M, et al. Conference contribution Prospective Clinical Phase II Results on Treosulfan-Based Conditioning Treatment of 70 Paediatric Patients with Haematological Malignancies (2018) Kalwak K, Bader P, Styczynski J, Gruhn B, Patrick K, Sedlacek P, Stachel D, et al. Conference contribution Infection and Predictors of Outcome of Cirrhotic Patients after Emergency Care Hospital Admission (2018) Safi W, Elnegouly M, Schellnegger R, Umgelter K, Geisler F, Reindl W, Saugel B, et al. Journal article European myeloma network recommendations on tools for the diagnosis and monitoring of multiple myeloma: What to use and when (2018) Caers J, Garderet L, Kortuem KM, O'Dwyer ME, Van De Donk NWCJ, Binder M, Dold SM, et al. Journal article